U.S. Mulls Implications of Early Use of HIV Drugs to Stop AIDS Spread
May 27, 2011
The U.S. global AIDS coordinator is leading discussions within the government about the ramifications of recent landmark research showing the public health benefits of early antiretroviral therapy for people with HIV. This month, the federal government announced that a large clinical trial proved early HIV treatment, given before the immune system faltered, reduced transmission of the virus to heterosexual partners by 96 percent.
"This is a study that needs to challenge the way we've been doing business," said Dr. Eric Goosby. "We need to ask ourselves if this indeed presents an opportunity for us to be more effective in preventing new [HIV] infections. What I'm now committed to doing is shepherding the dialogue within the U.S. government -- to go quickly, but I want to do it consciously."
05.26.2011; Richard Knox
This article was provided by CDC National Prevention Information Network. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update.
Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)